Skip to main content
Heart logoLink to Heart
. 2005 May;91(5):613–617. doi: 10.1136/hrt.2003.028316

Detection of myocardial viability by dobutamine stress echocardiography: incremental value of diastolic wall thickness measurement

T Zaglavara 1, T Pillay 1, H Karvounis 2, R Haaverstad 1, G Parharidis 2, G Louridas 2, A Kenny 1
PMCID: PMC1768879  PMID: 15831644

Abstract

Objective: To assess the diagnostic accuracy of baseline diastolic wall thickness (DWT) alone and as an adjunct to dobutamine stress echocardiography (DSE) for prediction of myocardial viability in patients with ischaemic left ventricular (LV) dysfunction, with the recovery of resting function after revascularisation as the yardstick.

Patients: 24 patients with ischaemic LV dysfunction (ejection fraction < 40%) scheduled for surgical revascularisation.

Setting: Regional cardiothoracic centre.

Methods: All patients underwent DSE before and resting echocardiography six months after revascularisation. DWT was measured in each of the 16 LV segments. A receiver operating characteristic (ROC) and a multi-ROC curve were generated to assess the ability of DWT alone and in combination with DSE to predict myocardial viability.

Results: DWT > 0.6 cm provided a sensitivity of 80%, a specificity of 51%, and a negative predictive value of 80% for the prediction of viability in akinetic segments. DSE had an excellent specificity (92%) but a modest sensitivity (60%) in akinetic segments. A combination of improvement at DSE or DWT > 0.8 cm improved sensitivity (90% v 60%, p < 0.001) and negative predictive value (92% v 78%, p  =  0.03) in akinetic segments compared with DSE alone. This was achieved with some loss in specificity (75% v 92%, p  =  0.01) and positive predictive value (71% v 82%, p  =  0.79).

Conclusions: DWT measurement may improve the sensitivity of DSE for the detection of myocardial viability. Akinetic segments with DWT > 0.8 cm have a good chance of recovery despite the absence of contractile reserve during DSE. Further testing may be required before excluding myocardial viability in these cases.

Keywords: hibernating myocardium, myocardial viability, dobutamine stress echocardiography, diastolic wall thickness


The presence of myocardial viability in patients with severe ischaemic left ventricular (LV) dysfunction has major implications for management and prognosis.1,2 Among the several tests used, detection of contractile reserve during dobutamine infusion has emerged as a non-invasive, safe, and accurate method for the detection of viable myocardium.3,4 Myocardial thinning occurs in areas of myocardial necrosis5,6 and preserved diastolic wall thickness (DWT) in dysfunctional segments may therefore indicate significant myocardial viability. Regional DWT can be easily measured off line from the baseline images acquired during a routine dobutamine stress echocardiography (DSE) study, with no additional patient discomfort or cost. The present study assessed the diagnostic accuracy of baseline DWT measurement alone and as an adjunct to standard DSE for the prediction of segmental recovery of function at six months after revascularisation in patients with severe ischaemic LV dysfunction.

METHODS

The study group consisted of 24 patients with ischaemic LV dysfunction (ejection fraction < 40%) scheduled for coronary artery bypass grafting (CABG) at the Freeman Cardiothoracic Centre (table 1). Patients with a recent acute ischaemic event (< 6 weeks), coronary anatomy unsuitable for complete revascularisation, or inadequate image quality were not included. All patients underwent DSE at one week preoperatively and resting echocardiography at six months after CABG. The patients’ medications, including β blockers, were not discontinued for the study.7 The studies performed did not influence the decision to proceed with revascularisation. The hospital’s ethics committee approved the study and informed consent was obtained from all patients.

Table 1.

 Clinical, angiographic, and operative data of study patients (n = 24)

Number (%)
EF 25–40% 17 (71%)
EF <25% 7 (29%)
History of myocardial infarction 17 (71%)
Stable angina 17 (71%)
Dyspnoea (NYHA I–II) 7 (29%)
Dyspnoea (NYHA III–IV) 10 (42%)
Q waves on ECG 15 (63%)
Previous CABG 1 (4%)
Previous PTCA 1 (4%)
Diabetes 5 (21%)
Hypertension 14 (58%)
Hyperlipidaemia 20 (83%)
Smoking 15 (63%)
β Blockers 18 (75%)
Calcium blockers 9 (38%0
Long acting nitrates 7 (29%)
ACE inhibitors 18 (75%)
Diuretics 9 (38%)
Two vessel disease 3 (12%)
Three vessel disease 21 (88%)
Number of distal coronary anastomoses
    2 3 (12%)
    3 5 (21%)
    4 15 (63%)
    5 1 (4%)

ACE, angiotensin converting enzyme; CABG, coronary artery bypass grafting; EF, ejection fraction; NYHA, New York Heart Association; PTCA, percutaneous coronary angioplasty.

Echocardiography

An ATL HDI 5000CV system was used and all studies were carried out with a single broadband transducer (3/2 MHz) and tissue harmonic imaging.8 DSE studies were performed as previously described.7 During analysis all DSE stages were considered for detection of contractile reserve, as the majority of patients were taking β blockers.7,9

The standard 16 segment model10 was used for wall motion analysis and DWT measurement. All studies were interpreted in random order by a consensus of two experienced observers blinded to the patients’ names and other clinical data. A wall motion score index was assigned to each stage of the test. Evidence of wall thickening in a previously akinetic segment or normalisation of thickening in a previously hypokinetic segment was regarded as the criterion of myocardial viability in the preoperative study. The same criteria were used to define recovery of resting segmental wall motion postoperatively. Evidence of hypokinesia, akinesia, or dyskinesia in a previously normokinetic segment or of akinesia or dyskinesia in a previously hypokinetic segment was considered the criterion of inducible ischaemia in the preoperative study. LV ejection fraction was calculated off line from the apical two and four chamber views by the standard Simpson’s method.

DWT measurement

DWT was measured off line for each of the 16 LV segments by two observers blinded to the patients’ names and clinical and DSE data. The resting preoperative end diastolic frames providing the best possible visualisation of the endocardial and epicardial borders were selected for analysis. The mean value (in centimetres) of three measurements from the leading endocardial edge to leading epicardial edge11,12 was assigned to each segment. The intraobserver and interobserver variabilities were 0.04 (0.01) cm and 0.05 (0.02) cm, respectively.

Statistical analysis

To assess the ability of DWT to predict postoperative recovery of resting function, a receiver operating characteristic (ROC) curve was generated. The area under the ROC curve (AUC) along with the corresponding 95% confidence interval (CI) is reported. The sensitivity and specificity of DSE alone are reported with 95% CIs. Lastly, to assess whether combining the tests improved accuracy, a multi-ROC curve was generated for which the test variable was: (1) positive DSE test and positive DWT; or (2) positive DSE test or positive DWT. Akinetic and hypokinetic segments were then analysed separately.

RESULTS

Baseline echocardiography

Of 384 myocardial segments analysed, 248 (65%) were dysfunctional (114 hypokinetic and 134 akinetic). Accurate measurement of DWT was possible in 94% of all segments and in 96% of the dysfunctional segments. The mean (SD) DWT was significantly higher in normal than in dysfunctional segments (1.08 (0.29) cm v 0.83 (0.31) cm, p < 0.001). Hypokinetic segments had a higher DWT than did akinetic segments (0.92 (0.27) cm v 0.74 (0.32) cm, p < 0.001).

Dobutamine stress echocardiography

The full protocol was completed for 17 patients and was stopped at stages 3 and 4 for the remaining patients (achievement of target heart rate or evidence of inducible ischaemia). Mean (SD) heart rate was 65(18) beats/min at rest and increased to 96 (23) beats/min at peak stress. No significant adverse events occurred.

The response of the 248 dysfunctional segments to dobutamine was as follows: continuous improvement was observed in 84 segments (34%), biphasic response in 38 (15%), worsening in 8 (3%), and no change in 118 segments (48%). Dyskinesia at peak stress without improvement at low dose developed in 2% of the akinetic segments. In addition, deterioration of function was observed in 11% (15 of 136) of the segments that were normal at baseline. Evidence of myocardial viability (continuous improvement or biphasic response) was observed in 28% (38 of 134) of the akinetic segments and in 75% (85 of 114) of the hypokinetic segments. Thus, myocardial viability was detected more often in hypokinetic than in akinetic segments (p < 0.001).

Effect of coronary revascularisation on regional LV function

None of the patients had angina at six months after CABG. Mean (SD) resting wall motion score index decreased to 1.66 (0.41) v 2.00 (0.43) preoperatively (p < 0.005). Mean (SD) ejection fraction increased from 29 (8)% to 39 (12)% (p < 0.005). Of the 248 dysfunctional segments, 111 (45%) had improved function at the follow up study (fig 1). In particular, improved function was evident in 52 of the 134 akinetic segments (39%), 38 of which improved to hypokinesis and 14 to normal function. Of the 114 hypokinetic segments 59 (52%) resumed normal function after revascularisation. None of the three akinetic segments that became dyskinetic at peak stress without improvement at low dose recovered function after revascularisation.

Figure 1.

Figure 1

 Chart showing the postoperative outcome of 128 revascularised akinetic segments grouped according to diastolic wall thickness (DWT) and response to dobutamine stress echocardiography. CR, contractile reserve; Rec, functional recovery.

Accuracy of DSE in predicting recovery of segmental resting LV function at six months after CABG

Of the 111 dysfunctional segments with improved function at follow up, 86 (77%) had also improved during DSE, whereas 93 of the 137 (68%) segments with no recovery of function had not improved during DSE. Improvement in akinetic segments during DSE had an excellent specificity but a modest sensitivity for recovery of resting function after CABG, whereas improvement in hypokinetic segments was more sensitive but less specific (table 2).

Table 2.

 Diagnostic accuracy of dobutamine stress echocardiography (DSE) in predicting recovery of segmental function at six months after CABG

Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
All segments 77 (69 to 84) 68 (60 to 75) 66 (58 to 74) 78 (71 to 85) 72(66 to 78)
Akinetic 60 (46 to 72) 92 (83 to 96) 82 (67 to 91) 78 (69 to 85) 79 (72 to 86)
Hypokinetic 93 (84 to 97) 33 (22 to 45) 60 (50 to 69) 82 (62 to 93) 64 (55 to 73)
p Value 0.001 <0.001 0.03 0.99 0.03

95% confidence intervals are shown.

NPV, negative predictive value; PPV, positive predictive value.

Accuracy of DWT in predicting recovery of segmental resting LV function at six months after CABG

Preoperative DWT was greater in myocardial segments with recovered resting function after CABG than in segments with no recovery (0.92 (0.32) v 0.75 (0.28) cm, p < 0.001). The AUC for DWT was 0.67 (95% CI 0.60 to 0.74, p < 0.001) for all dysfunctional segments, 0.53 (95% CI 0.42 to 0.64, p  =  0.624) for hypokinetic segments, and 0.75 (95% CI 0.66 to 0.84, p < 0.001) for akinetic segments. Although the area was > 0.5 the excess predictive ability of DWT for hypokinetic segments was not significant. DWT measurement was therefore found to be useful for the prediction of recovery of function after CABG only in akinetic segments (table 3).

Table 3.

 Accuracy of DSE, diastolic wall thickness (DWT), and their combination in predicting recovery of function at six months after CABG in akinetic segments

Sensitivity (%) Specificity (%) PPV (%) NPV (%)
DWT >0.6 cm 80 (68 to 89) 51 (40 to 62) 52 (41 to 63) 80 (66 to 89)
DWT >0.8 cm 61 (47 to 73) 78 (67 to 86) 65 (50 to 77) 75 (65 to 83)
DSE 60 (46 to 72) 92 (83 to 96) 82 (67 to 91) 78 (69 to 85)
DSE or DWT >0.6 cm 90 (79 to 96) 49 (38 to 60) 54 (44 to 64) 88 (76 to 95)
DSE or DWT >0.8 cm 90 (79 to 96) 75 (65 to 84) 71 (59 to 80) 92 (83 to 97)
DSE and DWT >0.6 cm 49 (36 to 62) 94 (86 to 97) 83 (66 to 93) 74 (64 to 81)

Combining DWT and DSE in predicting recovery of segmental resting LV function at six months after CABG

All segments

The AUC for DSE was 0.73 (95% CI 0.66 to 0.79) versus 0.67 (95% CI 0.60 to 0.70) for DWT. The sensitivity and specificity of DSE in predicting recovery of resting function were 77% (95% CI 69% to 84%) and 68% (95% CI 60% to 75%), respectively. To achieve the same sensitivity with DWT as the test variable, the cut off required would be 0.73 cm. However, the corresponding specificity would be only 49%. The combination of DSE or DWT produced an AUC of 0.73 (95% CI 0.59 to 0.80, p  =  0.002). The combination of DSE and DWT produced an AUC of 0.49 (95% CI 0.38 to 0.60, p  =  1.0).

Hypokinetic segments

The AUC for DSE was 0.63 (95% CI 0.53 to 0.73) versus 0.53 (95% CI 0.42 to 0.64) for DWT. The combination of DSE or DWT produced an AUC of 0.26 (95% CI 0.09 to 0.56) and the combination of DSE and DWT produced an AUC of 0.53 (95% CI 0.40 to 0.65) indicating no incremental value of DWT in addition to DSE alone in hypokinetic segments.

Akinetic segments

The AUC for DSE was 0.76 (95% CI 0.67 to 0.85) versus 0.75 (95% CI 0.66 to 0.84) for DWT. The combination of DSE or DWT produced an area under the multi-ROC curve of 0.79 (95% CI 0.65 to 0.89) indicating a slight improvement compared with DSE alone. A combination of improvement at DSE or DWT > 0.8 cm significantly improved sensitivity (90% v 60%, p < 0.001) and negative predictive value (92% v 78%, p  =  0.03) compared with DSE alone. This was achieved with the cost of some loss in specificity (75% v 92%, p  =  0.01) and positive predictive value (71% v 82%, p  =  0.79) (table 3).

DISCUSSION

Since the introduction of the concept of hibernating myocardium,13,14 several non-invasive tests have been extensively evaluated for their accuracy to predict functional recovery after revascularisation in patients with chronic ischaemic LV dysfunction.15–17 Among them, detection of contractile reserve during dobutamine infusion has emerged as a safe, non-invasive, and accurate method of identifying viable myocardium and is the technique of first choice in many centres with available equipment and expertise for this method.4,18 Several previous studies19–21 have established, however, that DSE is highly specific but modestly sensitive for the prediction of functional recovery in akinetic segments. Thus, it is apparent that certain myocardial segments are resistant to dobutamine stimulation but eventually recover function after revascularisation and are therefore judged to be hibernating. Exhausted coronary flow reserve,22 myofibrillar loss,23 and disruption of intercellular conduction24 are some of the mechanisms proposed to explain the phenomenon of dobutamine resistant yet viable myocardium.

In patients with severe ischaemic LV dysfunction, the clinical decision to recommend revascularisation is based on the presence of myocardial viability and has major implications for management and prognosis. It is becoming increasingly clear, however, that more than one method for viability detection may be necessary at times to make the correct management decision in certain cases.

Myocardial thinning and increase in echoreflectivity are long known to occur in areas of scar tissue caused by chronic transmural myocardial infarction.5,6 More recently a normal DWT and acoustic reflectance were reported to predict viable myocardium25 and a DWT of ⩽ 0.6 cm was reported to virtually exclude viability26 in patients with healed Q wave myocardial infarction. La Canna and colleagues12 reported that a DWT < 0.5 cm on echocardiography was the best predictor of non-recovery of function in patients with chronic ischaemic LV dysfunction. Cwajg and colleagues11 reported that DWT measurement can predict recovery of function in patients with suspected myocardial hibernation, similar to thallium-201 scintigraphy, and that a DWT of ⩽ 0.6 cm practically excludes a relevant amount of viable myocardium.

Most previous reports have, however, focused mainly on the high predictive accuracy of reduced DWT to exclude any significant amount of myocardial viability. In the present study, and in agreement with the previous reports,11,12,25,26 a DWT of ⩽ 0.6 cm on baseline echocardiography excluded the presence of significant viability with a negative predictive accuracy similar to that of DSE. However, in our study group DWT was ⩽ 0.6 cm in only 39% of akinetic segments and > 0.8 cm in 35% of akinetic segments. We extended previous observations22–24 to hypothesise that the possible changes that render the hibernating myocardium non-responsive to dobutamine may occur at an earlier stage than the ultrastructural changes that lead to myocardial thinning. Indeed, myocardial segments with a DWT of > 0.8 cm had a recovery rate of 63% (17 of 27) despite the absence of inotropic response during DSE (fig 1). A DWT of > 0.8 cm as a single parameter produced a specificity of 78% and a positive predictive value of 65% for functional recovery in akinetic segments. The combination of DSE response or DWT > 0.8 cm produced the highest negative predictive accuracy (92%) with a good balance between sensitivity (90%) and specificity (75%) for functional recovery in akinetic segments.

In agreement with Elhendy and colleagues27 we observed that akinetic segments that became dyskinetic at peak stress without improvement at low dose dobutamine did not recover function postoperatively. However, only 2% of akinetic segments had this type of response in our study group, probably due to the submaximal stress achieved.

In agreement with previous reports18,19,28 and in contrast to akinetic segments, in this study DSE had high sensitivity but rather low specificity to predict recovery of resting function in hypokinetic segments. At rest, most LV wall thickening occurs as a result of endocardial thickening, and if the endocardium is necrosed resting function is diminished despite the presence of healthy tissue in the middle and outer myocardial layers.6,29,30 In the present study DWT measurement had no excess predictive accuracy in addition to DSE in hypokinetic segments. Cwajg and colleagues11 reported a significant improvement in specificity when the criterion of DWT of > 0.6 cm is added to DSE response in hypokinetic segments. However, myocardial segments with a DWT of < 0.6 cm are usually akinetic rather than hypokinetic,6 and as the authors explain this increase in specificity may be due to exclusion of thin, non-viable segments that exhibit tethering during DSE. Furthermore, hypokinesia indicates that most of the myocardium has escaped necrosis and is hence viable.30 The presence of inducible ischaemia rather than viability is of clinical concern in these cases.

Study advantages and limitations

Functional recovery after revascularisation may be delayed, particularly in severely dysfunctional, akinetic myocardial segments. We therefore assessed functional outcome at six months after CABG, a time interval previously shown to be most appropriate.31

Accurate measurement of DWT requires good delineation of epicardial and endocardial borders and it is not feasible in certain patients who present technical difficulties. All studies were carried out with tissue harmonic imaging, previously shown to dramatically improve image quality and endocardial border delineation.8 Patients whose echocardiograms were of inadequate quality, despite the use of harmonic imaging, were not included in the study.

The study group consisted of patients with chronic ischaemic LV dysfunction. Findings do not apply to patients with acute or recent myocardial infarction, in whom an increased DWT may indicate myocardial damage and interstitial oedema after reperfusion rather than the presence of myocardial viability.32

Although angiography was not repeated at six months after CABG to assess graft patency, early graft function was assessed intraoperatively in 10 patients as a quality control of the effectiveness of revascularisation33 and was found to be satisfactory.

Conclusions and clinical implications

Regional DWT can be easily measured during DSE with no additional patient discomfort or cost and is a valuable adjunct to DSE for the detection of hibernating myocardium.

A DWT of ⩽ 0.6 cm on baseline echocardiography can exclude the presence of significant viability with a negative predictive accuracy similar to that of DSE. Absence of inotropic response to dobutamine in akinetic segments with a DWT of < 0.8 cm can exclude the presence of significant viability with an extremely high negative predictive accuracy. However, akinetic myocardial segments with a DWT of > 0.8 cm have a good chance of recovery even in the absence of contractile reserve during DSE. Further testing may be required before myocardial viability can be excluded in these cases.

Acknowledgments

This work has been supported with a research grant from the Medical Research Programme (Fourth Framework) of the European Commission. The authors are indebted to Mrs S Charman MSc for providing expert statistical advice and to Mr B Cumberledge and Mrs J Schuster for their technical assistance during the studies.

Abbreviations

  • AUC, area under the receiver operating characteristic curve

  • CABG, coronary artery bypass grafting

  • CI, confidence interval

  • DSE, dobutamine stress echocardiography

  • DWT, diastolic wall thickness

  • LV, left ventricular

  • ROC, receiver operating characteristic

REFERENCES

  • 1.Pasquet A, Robert A, D’Hondt AM, et al. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular dysfunction. Circulation 1999;100:141–8. [DOI] [PubMed] [Google Scholar]
  • 2.Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol 1999;33:1848–54. [DOI] [PubMed] [Google Scholar]
  • 3.Vanoverschelde JL, Pasquet A, Gerber B, et al. Pathophysiology of myocardial hibernation: implications for the use of dobutamine echocardiography to identify myocardial viability. Heart 1999;82 (suppl III) :iii1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bax JJ, Wijns W, Cornel JH, et al. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451–60. [DOI] [PubMed] [Google Scholar]
  • 5.Rasmussen S, Corya BC, Feigenbaum H, et al. Detection of myocardial scar tissue by M-mode echocardiography. Circulation 1978;57:230–7. [DOI] [PubMed] [Google Scholar]
  • 6.Lieberman AN, Weiss JL, Jugdutt BI, et al. Two-dimensional echocardiography and infarct size: relationship of regional wall motion and thinning to the extent of myocardial infarction in the dog. Circulation 1981;63:739–46. [DOI] [PubMed] [Google Scholar]
  • 7.Zaglavara T, Haaverstad R, Cumberledge B, et al. Dobutamine stress echocardiography for the detection of myocardial viability in patients with left ventricular dysfunction taking β-blockers: accuracy and optimal dose. Heart 2002;87:329–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Zaglavara T, Norton M, Cumberledge B, et al. Dobutamine stress echocardiography: improved endocardial border definition and wall motion analysis with tissue harmonic imaging. J Am Soc Echocardiogr 1999;12:706–13. [DOI] [PubMed] [Google Scholar]
  • 9.Poldermans D, Sozzi FB, Bax JJ, et al. Influence of continuation of beta blockers during dobutamine stress echocardiography for the assessment of myocardial viability in patients with severe ischemic left ventricular dysfunction. Am J Cardiol 2001;88 A7,68–70. [DOI] [PubMed] [Google Scholar]
  • 10.Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 1989;2:358–67. [DOI] [PubMed] [Google Scholar]
  • 11.Cwajg JM, Cwajg E, Nagueh SF, et al. End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest-redistribution Tl-201 tomography and dobutamine stress echocardiography. J Am Coll Cardiol 2000;35:1152–61. [DOI] [PubMed] [Google Scholar]
  • 12.La Canna G, Rahimtoola SH, Visioli O, et al. Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium. Eur Heart J 2000;21:1358–67. [DOI] [PubMed] [Google Scholar]
  • 13.Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for “hibernating myocardium”. J Am Coll Cardiol 1986;8:1467–70. [DOI] [PubMed] [Google Scholar]
  • 14.Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211–21. [DOI] [PubMed] [Google Scholar]
  • 15.Wijns W, Vatner SF, Camici PG. Hibernating myocardium. N Engl J Med 1998;339:173–81. [DOI] [PubMed] [Google Scholar]
  • 16.Vanoverschelde JL, Gerber BL, D’Hondt AM, et al. Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization: role of low-dose dobutamine echocardiography and exercise-redistribution-reinjection thallium SPECT. Circulation 1995;92 (suppl II) :ii37–44. [DOI] [PubMed] [Google Scholar]
  • 17.Wiggers H, Nielsen TT, Bottcher M, et al. Positron emission tomography and low-dose dobutamine echocardiography in the prediction of postrevascularization improvement in left ventricular function and exercise parameters. Am Heart J 2000;140:928–36. [DOI] [PubMed] [Google Scholar]
  • 18.Vanoverschelde JL, D’Hondt AM, Marwick T, et al. Head to head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996;28:432–42. [DOI] [PubMed] [Google Scholar]
  • 19.Perrone-Filardi P, Pace L, Prastaro M, et al. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995;91:2556–65. [DOI] [PubMed] [Google Scholar]
  • 20.Arnese M, Cornel JH, Salustri A, et al. Prediction of improvement of regional left ventricular function after surgical revascularization: a comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. Circulation 1995;91:2748–52. [DOI] [PubMed] [Google Scholar]
  • 21.Nagueh SF, Vaduganathan P, Ali N, et al. Identification of hibernating myocardium: comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography. J Am Coll Cardiol 1997;29:985–93. [DOI] [PubMed] [Google Scholar]
  • 22.Bonow RO. Identification of viable myocardium. Circulation 1996;94:2674–80. [DOI] [PubMed] [Google Scholar]
  • 23.Pagano D, Townend JN, Parums DV, et al. Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake. Heart 2000;83:456–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kaprielian RR, Gunning M, Dupont E, et al. Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation 1998;97:651–60. [DOI] [PubMed] [Google Scholar]
  • 25.Faletra F, Crivellaro W, Pirelli S, et al. Value of transthoracic two-dimensional echocardiography in predicting viability in patients with healed Q-wave anterior wall myocardial infarction. Am J Cardiol 1995;76:1002–6. [DOI] [PubMed] [Google Scholar]
  • 26.Schinkel AF, Bax JJ, Boersma E, et al. Assessment of residual myocardial viability in regions with chronic electrocardiographic Q-wave infarction. Am Heart J 2002;144:865–9. [DOI] [PubMed] [Google Scholar]
  • 27.Elhendy A, Cornel JH, Roelandt JR, et al. Akinesis becoming dyskinesis during dobutamine stress echocardiography: a predictor of poor functional recovery after surgical revascularization. Chest 1996;110:155–8. [DOI] [PubMed] [Google Scholar]
  • 28.Cornel JH, Bax JH, Elhendy A, et al. Predictive accuracy of echocardiographic response of mildly dyssynergic myocardial segments to low-dose dobutamine. Am J Cardiol 1997;80:1481–4. [DOI] [PubMed] [Google Scholar]
  • 29.Kaul S . There may be more to myocardial viability that meets the eye. Circulation 1995;92:2790–3. [DOI] [PubMed] [Google Scholar]
  • 30.Kaul S . Response of dysfunctional myocardium to dobutamine. “The eyes see what the mind knows!” J Am Coll Cardiol 1996;27:1608–11. [DOI] [PubMed]
  • 31.Haas F, Augustin N, Holper K, et al. Time course and extent of improvement of dysfunctional myocardium in patients with coronary artery disease and severely depressed left ventricular function after revascularization: correlation with positron emission tomographic findings. J Am Coll Cardiol 2000;36:1927–34. [DOI] [PubMed] [Google Scholar]
  • 32.Oh H, Ito H, Iwakura K, et al. Temporal changes in regional end-diastolic wall thickness early after reperfusion in acute anterior myocardial infarction: relation to myocardial viability and vascular damage. Am Heart J 1996;131:1113–20. [DOI] [PubMed] [Google Scholar]
  • 33.Walpoth BH, Bosshard A, Genyk I, et al. Transit-time flow measurement for detection of early graft failure during myocardial revascularization. Ann Thorac Surg 1998;66:1097–100. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES